Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Diets impact Parkinson's motor symptoms, supplements show no benefit, study finds

In a recent meta-analysis and systematic review published in the European Journal of Clinical Nutrition, researchers collated and reanalyzed data on the effects of diets (and, by extension, dietary patterns and supplements) in accelerating or attenuating Parki

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

In a recent meta-analysis and systematic review published in the European Journal of Clinical Nutrition, researchers collated and reanalyzed data on the effects of diets (and, by extension, dietary patterns and supplements) in accelerating or attenuating Parkinson’s disease (PD). Their review and reassessment of data from 24 publications reveals that the Mediterranean, ketogenic, and other low-protein dietary regimes could effectively lower the total Unified Parkinson Disease Rating Scale (UPDRS) score, improving overall motor function. Contrary to prior hypotheses, however, dietary interventions, including supplementation, were not observed to improve UPDRS or six-min walk test (6MWT) distance scores.

Neurodegenerative diseases and diets

Neurodegenerative diseases are age-related chronic non-transmissible conditions characterized by the loss of function of the peripheral nervous system or brain cells. Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the two most prevalent examples of neurodegenerative diseases, with the latter affecting more than 1% of all humans above 60, making it the most common movement disorder in the world.

Unfortunately, as is the case for most neurodegenerative conditions, no cure for PD currently exists, with clinical interventions aimed at managing the condition and slowing its progress and research focused on PD prevention. The recent surge in PD incidence has been primarily attributed to the global evolution of dietary consumption and health behaviors, with suboptimal Western-style dietary regimes and sedentary lifestyles deemed the main culprits.

“A healthy diet, lifestyle enhancement, antioxidant agents, and nutrients targeting anti-inflammatory can be a potentially effective strategy for treating PD.”

A growing body of scientific evidence suggests the profound association between dietary choices and age-related clinical outcomes, with some diets observed to accelerate the onset and progression of PD while others reduce the risk of acquiring the disease. Despite many randomized controlled trials (RCTs) and crossover studies revealing the dietary benefits, primarily related to the gut microbiome, of maintaining healthy diets, reviews and meta-analyses discussing their findings and consolidating their results remain severely lacking.

About the study

The present study is registered with the International Prospective Register of Systematic Reviews (PROSPERO) database, and its methodologies were designed to comply with both the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data for the study was collated from eight online scientific publication repositories, namely PubMed, Embase, Medline, Cochrane Library, SCOPUS, Wanfang, China National Knowledge Infrastructure (CNKI), and Weipu, from database initiation till June 26, 2022.

Study inclusion criteria comprised study type (randomized controlled trial [RCTs]), language (English), study interventions, clinically confirmed PD, and results reported as Unified Parkinson Disease Rating Scale (UPDRS) or International Parkinson and Movement Disorder Society UPDRS (MDS-UPDRS) total score, UPDRS or MDS-UPDRS motor score, six-min walk test (6MWT), or quantitative insulin sensitivity check index (QUICKI).

Publication selection comprised title, abstract, and full-text screening phases, with in vitro experiments excluded from the analyses. Data extraction included study characteristics, patient sample size, dietary interventions (including intervention durations), and results. The Cochrane Risk of Bias instrument for randomized trials version 2 (ROB2) was used to assess included publications for bias risk across all five of its recommended parameters. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool was additionally used to evaluate data quality and effectiveness.

Mean differences (MDs) and standard deviations (SDs) were used to standardize results for meta-analyses conducted in the Cochrane Collaboration’s Review Manager 5.4 software. I2 was computed to evaluate the degree of discrepancy between studies and the Chi-square test to estimate between-test heterogeneity. Finally, sensitivity analyses were carried out to assess potential publication bias.

Study findings

Initial database screening revealed 9,970 studies titles pertaining to the topic, 291 of which were duplicates. Abstract screening narrowed down the list to 28, which full-text screening further shortened to the final set of 24 publications.

Results of the present meta-analyses elucidate that while QUICKI indices depict improvements following dietary supplementation, UPDRS (and its derivatives) and 6MWT scores show no such improvements. In contrast, systematic review findings suggest that some nutritional regimes, particularly the Mediterranean diet, ketogenic diets, and other diets featuring low-protein intakes, significantly lowered UPDRS scores and mitigated motor PD symptoms.

“In the future, it is necessary to conduct a studies sample size with sufficient power to evaluate how different kinds of dietary intervention affect people with PD.”

  • Wu, L., Chu, L., Pang, Y. et al. Effects of dietary supplements, foods, and dietary patterns in Parkinson’s disease: meta-analysis and systematic review of randomized and crossover studies. Eur J Clin Nutr (2024), DOI – 10.1038/s41430-024-01411-1, https://www.nature.com/articles/s41430-024-01411-1

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What’s your vision for BenevolentBio?

I want us to disrupt the drug discovery and development process and to look at each place on the drug discovery and development pipeline, so that we can be much better at getting the right target, much quicker at getting the right compound and much more confident that those compounds have the right characteristics which mean they will be safe and well tolerated. Then we can go to the right patient population with the right dose, so we would have a much leaner, more successful process and be able to demonstrate the value of our AI technology.

Source: www.news-medical.net ↗
02How will this discovery change cancer science?

This is a win for the field. Until now, we have been focused on immune therapies that might make tumors more vulnerable to the body's immune system, and on finding new chemotherapy combinations that kill cancer cells. This new treatment has given us a new focus, and I think it will spur a lot of scientific discovery over the next few years. There have only been a handful of KRAS researchers and their relevance to therapy was always questioned. That is about to change. The most important next step for the field is to better understand the biology of cancer. We know that many pancreatic tumors will eventually become resistant to daraxonrasib, and we need to understand how this happens. We also need to identify additional genetic pathways and treatments that can target them. That's how we will turn pancreas cancer from a deadly, deadly cancer into something we can manage-and one day, even cure.

Source: www.news-medical.net ↗
03What are carbs?

Your weight loss plan should keep you healthy and strong as you lose the extra weight. Many plans include a diet low in carbohydrates. Carb cycling is a method of optimizing your carbohydrate intake to meet your needs while dieting, fasting, and working out. When you're carb cycling, you consume carbs to meet your needs on some days and avoid them on other days. The aim of carb cycling is to consume carbohydrates when your body needs them and exclude them at other times. Such strategies in your diet plan can help your weight loss efforts. Carbohydrates, or carbs, are a significant part of the average human diet. Along with proteins and fats, they make up the bulk of your daily meals. Most carbohydrates are broken down by your body into glucose to provide energy for your cells and tissues. Carbohydrates in your diet are of three types — sugars, starches, and fiber. Sugars are simple carbs. Glucose, sugar (sucrose), lactose found in milk, and fructose found in fruits, are naturally occurring sugars. Your body metabolizes these molecules rapidly to yield energy. Starches are complex carbs. They're large molecules that consist of hundreds of molecules of simple sugars joined together. Your body needs to break them down to release energy. Starches are found in bread, potatoes, peas, corn, cereals, and pasta. Fiber is also a complex carbohydrate. Human bodies can't break down these large molecules, so they provide no energy. They're usually excreted as they are in the feces. They add bulk to your meal, so you feel full. Fiber in the diet helps avoid constipation and lowers blood sugar and cholesterol levels. Carbohydrates are an essential part of your diet. A typical diet provides 45% to 65% of its calories from carbohydrates. If you have 2,000 calories a day, you should have about 275 grams of carbohydrates. Always try to choose healthy foods for your carb intake:

Source: www.medicinenet.com ↗
04ApconiX's in vitro seizure liability assay (iSLA) platform provides a human-relevant approach for assessing seizure liability. Where can AI add the most value alongside assays like this?

There are several areas where AI could add value, but one of the most exciting is helping us translate complex experimental results into actionable insights for drug discovery teams. We see computational and experimental approaches as complementary rather than competing technologies. In vitro assays such as iSLAseizure generate highly relevant biological data, while AI and machine learning can help uncover patterns within that data that might otherwise be difficult to identify. One example is work I recently presented at the BioNow BioAI Symposium, in which we explored the use of structure-activity relationships (SAR) and machine learning models alongside iSLAseizure assay data. Supported by colleagues, including Dr. Louisa Zolkiewski and Dr. Kim Rockley, ApconiX has developed an in-house seizure liability dataset that we analyzed in collaboration with MedChemica. Using machine learning and chemical informatics approaches, we identified chemical substructures that show statistically significant relationships with seizure-related outcomes. The aim is not simply to predict risk, but to understand which molecular features may contribute to that risk and provide medicinal chemists with practical guidance they can apply much earlier in the discovery process. Looking ahead, I think this is where AI can have a particularly powerful impact. Rather than acting as a standalone prediction tool, it can work alongside human-relevant assays such as iSLAseizure to connect molecular structure, experimental biology, and safety outcomes. That combination has the potential to improve decision-making earlier in the discovery process, reduce late-stage safety surprises, and ultimately support the development of safer medicines for patients.

Source: www.news-medical.net ↗
05From Spirulina to Seaweed: How are different types of algae integral to human diets?

Algae are photosynthetic aquatic creatures that grow through the consumption of nutrients, light, and carbon dioxide. They are a diverse group of creatures that include tiny single-celled algae and enormous kelp, as well as seaweed 1. Numerous prokaryotic and eukaryotic algae species are desirable food sources for humans due to their inherent qualities 2,3. Human intake of macroalgae such as seaweed and microalgae like phytoplankton dates back many years. Multicellular macroscopic aquatic plants, or macroalgae, are classified into three taxa: Phaeophyceae, or brown algae, Rhodophyta or red algae, and Chlorophyta or green algae. Microalgae, the unicellular counterpart of macroalgae, are categorized in a broader framework that includes prokaryotic cyanobacteria (blue-green algae), Euglenophyta, and Chlorophyta, which are genetically distinct from one another. The ancient populations of Chad and the Aztec culture were already familiar with the cyanobacteria spirulina, which is currently advertised as a superfood in the West 4. In Burma, Vietnam, and India, other cyanobacteria/microalgae, like Spirogyra and Oedogonium, were eaten as food or as a supplement 4. Seaweed is a staple of daily meals in many Asian and Pacific civilizations, including Korea, Japan, and Indonesia, as well as Hawaii and New Zealand 5.

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →